The bone volume of Ctsk−/−-prednisolone mice indicated that Ctsk deletion in part helps rescue glucocorticoid-induced osteoporosis (GIO) (Yang et al., 2018), thereby making the Ctsk inhibitors effective in GIO prevention. Here, CTSK is linked to osteoporosis.